Phase 3
Completed N=349
Metoclopramide for Migraine: A Dose Finding Study
Source: ClinicalTrials.gov NCT00682734 ↗Enrolled (actual)
349
Serious AEs
0.3%
Results posted
Dec 2012
Primary outcomePrimary: Pain Intensity Score — 4.7; 4.9; 5.3 scores on a scale
Summary
Metoclopramide is an effective intravenous treatment for acute migraine attacks, but we do not know the best dose to administer. This study compares three different doses of metoclorpamide.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Pain Intensity Score |
4.7; 4.9; 5.3 | — |
Eligibility Criteria
Inclusion Criteria
- acute migraine
Exclusion Criteria
- secondary cause of headache
- lumbar puncture
- allergy or intolerance to study medication
Data sourced from ClinicalTrials.gov (NCT00682734). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.